150 related articles for article (PubMed ID: 31239664)
1. Mixed micelles loaded with the 5-benzylidenethiazolidine-2,4-dione derivative SKLB023 for efficient treatment of non-alcoholic steatohepatitis.
Li Y; Zhang T; Liu Q; Zhang J; Li R; Pu S; Wu T; Ma L; He J
Int J Nanomedicine; 2019; 14():3943-3953. PubMed ID: 31239664
[No Abstract] [Full Text] [Related]
2. SKLB023 as an iNOS inhibitor alleviated liver fibrosis by inhibiting the TGF-beta/Smad signaling pathway.
Zhang J; Li Y; Liu Q; Li R; Pu S; Yang L; Feng Y; Ma L
RSC Adv; 2018 Aug; 8(54):30919-30924. PubMed ID: 35548714
[TBL] [Abstract][Full Text] [Related]
3. SKLB023 blocks joint inflammation and cartilage destruction in arthritis models via suppression of nuclear factor-kappa B activation in macrophage.
Xie C; Ma L; Liu J; Li X; Pei H; Xiang M; Chen L
PLoS One; 2013; 8(2):e56349. PubMed ID: 23431370
[TBL] [Abstract][Full Text] [Related]
4. Soyasaponin A
Xiong F; Zheng Z; Xiao L; Su C; Chen J; Gu X; Tang J; Zhao Y; Luo H; Zha L
Mol Nutr Food Res; 2021 Jul; 65(14):e2100067. PubMed ID: 34047448
[TBL] [Abstract][Full Text] [Related]
5. Self-assembling polymer-based short chain fatty acid prodrugs ameliorate non-alcoholic steatohepatitis and liver fibrosis.
Shashni B; Tajika Y; Ikeda Y; Nishikawa Y; Nagasaki Y
Biomaterials; 2023 Apr; 295():122047. PubMed ID: 36840994
[TBL] [Abstract][Full Text] [Related]
6. Mixed Micelles Loaded with Bile Salt: An Approach to Enhance Intestinal Transport of the BCS Class III Drug Cefotaxime in Rats.
Arafat M; Kirchhoefer C; Mikov M
Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):635-645. PubMed ID: 27686853
[TBL] [Abstract][Full Text] [Related]
7. Comparison of bile salt/phosphatidylcholine mixed micelles in solubilization to sterols and stability.
Guo Q; Cai J; Li P; Xu D; Ni X; Wen H; Liu D; Lin S; Hu H
Drug Des Devel Ther; 2016; 10():3789-3798. PubMed ID: 27895469
[TBL] [Abstract][Full Text] [Related]
8. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
[TBL] [Abstract][Full Text] [Related]
9. Altered bile acid composition and disposition in a mouse model of non-alcoholic steatohepatitis.
Suga T; Yamaguchi H; Ogura J; Shoji S; Maekawa M; Mano N
Toxicol Appl Pharmacol; 2019 Sep; 379():114664. PubMed ID: 31306673
[TBL] [Abstract][Full Text] [Related]
10. Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation.
Yan T; Wang H; Cao L; Wang Q; Takahashi S; Yagai T; Li G; Krausz KW; Wang G; Gonzalez FJ; Hao H
Drug Metab Dispos; 2018 Sep; 46(9):1310-1319. PubMed ID: 29959134
[TBL] [Abstract][Full Text] [Related]
11. Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor.
Aljobaily N; Krutsinger K; Viereckl MJ; Joly R; Menlove B; Cone B; Suppes A; Han Y
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615835
[TBL] [Abstract][Full Text] [Related]
12. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis.
Matsumoto M; Hada N; Sakamaki Y; Uno A; Shiga T; Tanaka C; Ito T; Katsume A; Sudoh M
Int J Exp Pathol; 2013 Apr; 94(2):93-103. PubMed ID: 23305254
[TBL] [Abstract][Full Text] [Related]
13. An estrogen receptor β-selective agonist inhibits non-alcoholic steatohepatitis in preclinical models by regulating bile acid and xenobiotic receptors.
Ponnusamy S; Tran QT; Thiyagarajan T; Miller DD; Bridges D; Narayanan R
Exp Biol Med (Maywood); 2017 Mar; 242(6):606-616. PubMed ID: 28092182
[TBL] [Abstract][Full Text] [Related]
14. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
[TBL] [Abstract][Full Text] [Related]
15. Nicotinic alpha-7 acetylcholine receptor deficiency exacerbates hepatic inflammation and fibrosis in a mouse model of non-alcoholic steatohepatitis.
Kimura K; Inaba Y; Watanabe H; Matsukawa T; Matsumoto M; Inoue H
J Diabetes Investig; 2019 May; 10(3):659-666. PubMed ID: 30369082
[TBL] [Abstract][Full Text] [Related]
16. Modulatory role of Co-enzyme Q10 on methionine and choline deficient diet-induced non-alcoholic steatohepatitis (NASH) in albino rats.
Saleh DO; Ahmed RF; Amin MM
Appl Physiol Nutr Metab; 2017 Mar; 42(3):243-249. PubMed ID: 28177750
[TBL] [Abstract][Full Text] [Related]
17. INT-767 improves histopathological features in a diet-induced
Roth JD; Feigh M; Veidal SS; Fensholdt LK; Rigbolt KT; Hansen HH; Chen LC; Petitjean M; Friley W; Vrang N; Jelsing J; Young M
World J Gastroenterol; 2018 Jan; 24(2):195-210. PubMed ID: 29375205
[TBL] [Abstract][Full Text] [Related]
18. Mixed micelles loaded with silybin-polyene phosphatidylcholine complex improve drug solubility.
Duan RL; Sun X; Liu J; Gong T; Zhang ZR
Acta Pharmacol Sin; 2011 Jan; 32(1):108-15. PubMed ID: 21170082
[TBL] [Abstract][Full Text] [Related]
19. Astaxanthin Prevents Diet-Induced NASH Progression by Shaping Intrahepatic Immunity.
Yang M; Kimchi ET; Staveley-O'Carroll KF; Li G
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681695
[TBL] [Abstract][Full Text] [Related]
20. The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
Bae CR; Zhang H; Kwon YG
PLoS One; 2020; 15(12):e0243497. PubMed ID: 33275637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
